171 related articles for article (PubMed ID: 35948981)
1. Clinical usefulness and acceleratory effect of macrophage inhibitory cytokine-1 on biliary tract cancer: an experimental biomarker analysis.
Sugimoto M; Suzuki R; Nozawa Y; Takagi T; Konno N; Asama H; Sato Y; Irie H; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Suzuki O; Hashimoto Y; Hikichi T; Ohira H
Cancer Cell Int; 2022 Aug; 22(1):250. PubMed ID: 35948981
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.
Sugimoto M; Takagi T; Konno N; Suzuki R; Asama H; Watanabe K; Nakamura J; Waragai Y; Kikuchi H; Takasumi M; Sato Y; Hikichi T; Ohira H
Sci Rep; 2017 Aug; 7(1):9198. PubMed ID: 28835660
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.
Dhar DK; Olde Damink SW; Brindley JH; Godfrey A; Chapman MH; Sandanayake NS; Andreola F; Mazurek S; Hasan T; Malago M; Pereira SP
Cancer; 2013 Feb; 119(3):575-85. PubMed ID: 22864959
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer.
Sugimoto M; Abe K; Hayashi M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hashimoto M; Hikichi T; Nozawa Y; Ohira H
Sci Rep; 2018 Nov; 8(1):16997. PubMed ID: 30451962
[TBL] [Abstract][Full Text] [Related]
5. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.
Jo JH; Park SB; Chung J; Oh T; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Jung DE; Song SY
BMC Cancer; 2024 Mar; 24(1):357. PubMed ID: 38509504
[TBL] [Abstract][Full Text] [Related]
6. MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.
Matull WR; Andreola F; Loh A; Adiguzel Z; Deheragoda M; Qureshi U; Batra SK; Swallow DM; Pereira SP
Br J Cancer; 2008 May; 98(10):1675-81. PubMed ID: 18475301
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
[TBL] [Abstract][Full Text] [Related]
8. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
10. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E
PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175
[TBL] [Abstract][Full Text] [Related]
11. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
[TBL] [Abstract][Full Text] [Related]
12. [Macrophage Inhibitory Cytokine-1 (MIC-1) as A Biomarker for Diagnosis
and Prognosis of Stage I-II Non-small Cell Lung Cancer].
Liu Y; Wang X; Wang T; Zhang C; Zhang K; Zang R; Zhi X; Zhang W; Sun K
Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):207-15. PubMed ID: 27118648
[TBL] [Abstract][Full Text] [Related]
13. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Role of Bile Pigment Components in Biliary Tract Cancer.
Ahn KS; Kang KJ; Kim YH; Kim TS; Cho KB; Kim HS; Baek WK; Suh SI; Han JY
Biomol Ther (Seoul); 2023 Nov; 31(6):674-681. PubMed ID: 37558633
[TBL] [Abstract][Full Text] [Related]
15. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.
Mimeault M; Batra SK
J Cell Physiol; 2010 Sep; 224(3):626-35. PubMed ID: 20578239
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for operable biliary tract cancer: serum levels of lactate dehydrogenase, a strong association with survival.
Ma L; Qiu J; Zhang Y; Qiu T; Wang B; Chen W; Li X; Sun J; Wang K; Li X; Gu Y; Shu Y; Chen X
Onco Targets Ther; 2018; 11():2533-2543. PubMed ID: 29765232
[TBL] [Abstract][Full Text] [Related]
17. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
[TBL] [Abstract][Full Text] [Related]
18. Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare.
Lee JH; Yu SE; Kim KH; Yu MH; Jeong IH; Cho JY; Park SJ; Lee WJ; Han SS; Kim TH; Hong EK; Woo SM; Yoo BC
EPMA J; 2018 Sep; 9(3):287-297. PubMed ID: 30174764
[TBL] [Abstract][Full Text] [Related]
19. Src as a Therapeutic Target in Biliary Tract Cancer.
Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Lee KH; Kim TY; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Mol Cancer Ther; 2016 Jul; 15(7):1515-24. PubMed ID: 27196758
[TBL] [Abstract][Full Text] [Related]
20. The effects of buthionine sulfoximine on the proliferation and apoptosis of biliary tract cancer cells induced by cisplatin and gemcitabine.
Li Q; Yin X; Wang W; Zhan M; Zhao B; Hou Z; Wang J
Oncol Lett; 2016 Jan; 11(1):474-480. PubMed ID: 26870236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
